₹560
▲ +18.41 +3.40%
27 Oct 2026
NSE Listed · Trading
Q-Line Biotech Limited (QLINE)
Volume: 8,400Avg Vol 1W: 93,600Avg Vol 1M: 85,70952W Range:₹431₹735
Key Ratios
Checked just nowMarket Cap₹1,306 Cr
Current Price₹560
Previous Close₹541.59
High / Low (52w)₹735 / ₹431
Volume8,400
Avg Vol (1W)93,600
Avg Vol (1M)85,709
Stock P/E23.06
Book Value₹209.24
Dividend Yield0%
ROE22.63%
ROA6.16%
Revenue (TTM)—
Revenue Growth—
Profit Margin17.38%
Total Debt—
Shares Outstanding2 Cr
Face Value—
EPS (TTM)₹24.28
P/B2.68
Debt / Equity0.9
50 DMA₹618.67
200 DMA—
Day change+3.40%
Price Chart
₹560▲ 17.99% · 1Y
2026-05-292026-10-27
20-day avg volume: 89K shares
Pros
- Healthy return on equity of 22.6%.
- Company is almost debt-free.
- Net profit is growing year over year.
Profit & Loss (Annual)
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | ₹185 Cr | ₹206 Cr | ₹322 Cr | ₹347 Cr |
| EBITDA | ₹34 Cr | ₹37 Cr | ₹72 Cr | ₹93 Cr |
| Net Profit | ₹32 Cr | ₹34 Cr | ₹19 Cr | ₹56 Cr |
| EPS | 20.38 | 21.87 | 12.2 | 34.79 |
Balance Sheet
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Total Assets | ₹252 Cr | ₹339 Cr | ₹455 Cr | ₹559 Cr |
| Total Liabilities | ₹124 Cr | ₹177 Cr | ₹266 Cr | ₹312 Cr |
| Equity | ₹127 Cr | ₹162 Cr | ₹190 Cr | ₹246 Cr |
| Total Debt | — | — | — | — |
Cash Flow
| Metric | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | ₹37 Cr | ₹-15 Cr | ₹26 Cr | ₹42 Cr |
| Investing | ₹-26 Cr | ₹-45 Cr | ₹-77 Cr | ₹-29 Cr |
| Financing | ₹26 Cr | ₹17 Cr | ₹53 Cr | ₹42 Cr |
| Free Cash Flow | ₹37 Cr | ₹-15 Cr | ₹26 Cr | ₹42 Cr |
Shareholding
Promoter 67.51% Institutions 9.03% Public 23.45%
Efficiency & Working Capital
ROCE19.4%
Interest Coverage4.7
Dividend Payout—
Debtor Days115 d
Inventory Days87 d
Payable Days48 d
Cash Conversion Cycle155 d
Working Capital Days202 d
Shareholding Details
As of 2026-09-30
Promoter67.5%
FII0.9%
DII8.2%
Institutions9%
Public23.5%
Promoter Pledge0%
No. of Shareholders2,948
Shareholding Pattern
Quarterly — figures in %. Latest 4 quarters.
| Period | Sept 2025 | May 2026 | May 2026 | Sept 2026 |
|---|---|---|---|---|
| Promoters | 96.8% | 67.5% | 67.5% | 67.5% |
| FIIs | 0% | 1.7% | 1.7% | 0.9% |
| DIIs | 0% | 10.1% | 10.1% | 8.2% |
| Public | 3.2% | 20.7% | 20.7% | 23.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% |
| No. of Shareholders | 24 | 3,497 | 3,497 | 2,948 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202603 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Saurabh Garg | Shareholding of Promoter and Promoter Group | 43.7% | 1.02 Cr |
| Amita Garg | Shareholding of Promoter and Promoter Group | 16.9% | 39,37,480 |
| Abhay Agrawal | Shareholding of Promoter and Promoter Group | 3.2% | 7,56,010 |
| Ajay Kumar Mahanty | Shareholding of Promoter and Promoter Group | 3.2% | 7,50,000 |
| Abakkus Small Cap Fund | Public Shareholding | 2.2% | 5,13,600 |
| Carnelian Aif Category I Trust-scheme 1 | Public Shareholding | 1.4% | 3,36,000 |
| Abakkus Flexi Edge Fund-1 | Public Shareholding | 1.1% | 2,45,600 |
| Amit Agarwal | Shareholding of Promoter and Promoter Group | 0.1% | 31,510 |
| Shubham Garg | Shareholding of Promoter and Promoter Group | 0.1% | 31,500 |
| Ayush Garg | Shareholding of Promoter and Promoter Group | 0.1% | 31,500 |
| Pushplata Garg | Shareholding of Promoter and Promoter Group | 0.1% | 21,000 |
| Radhey Shyam Agrawal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Beena Agarwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rachna Agrawal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Nivarani Puhan | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rakhahari Mohanty | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Kunjalata Mahanty | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rangalata Mohanty | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Snehalata Pradhan | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Rabindra Nath Puhan | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Biswajit Puhan | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Sujit Kumar Puhan | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shweta Agarwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Pooja Agarwal | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Asha Rani Vaish | Shareholding of Promoter and Promoter Group | 0% | 0 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Saurabh Garg | Chairman & Managing Director | 2025 |
| Kuldeep Chowdhry | Whole Time Director | 2025 |
| Ajay Kumar Mahanty | Whole-time Director | 2025 |
| Yethadka Subraya Prabhakara | Whole-time Director | 2025 |
| Abhay Agrawal | Non Executive Director | 2025 |
| Amita Garg | Non Executive Director | 2025 |
| Ayush Garg | Non Executive Director | 2025 |
| Abhishek Mishra | Independent Director | 2025 |
| Pravir Kumar | Independent Director | 2025 |
| ROHIT NANDAN | Independent Director | 2025 |
| Jai Prakash Singh | Independent Director | 2025 |
| Akhand Pratap Singh. | Company Secretary / Compliance Officer | 2025 |
Segments — Product
| Segment | Revenue | Share |
|---|---|---|
| Manufacturing | ₹230 Cr | 67.5% |
| Trading | ₹111 Cr | 32.5% |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2026 | ₹10 | 25 | 16 | 16 |
Company Information
🌐 www.qlinebiotech.com ↗
📍 298-281 Transport Nagar Kanpur, #NAME?, Lucknow, Uttar Pradesh, 226012
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
PVP VenturesPVR Inox LimitedPopular Vehicles & Services Ltd.Physicswallah LimitedPyramid Technoplast Ltd.Quality Foils (India) Ltd.QMS Medical Allied Services Ltd.Quality Power Electrical Equipments Ltd.Quadrant Future Tek Ltd.Quadpro ITES LimitedQualiance International LimitedQuess Corp LimitedAll “Q” stocks →
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search